Literature DB >> 17249194

Evaluation of neuroprotective effects of long-term low dose hormone replacement therapy on postmenopausal women brain hippocampus using magnetic resonance scanner.

Ling Hu1, Yun Yue, Ping-Ping Zuo, Zheng-Yu Jin, Feng Feng, Hui You, Ming-Li Li, Qin-Sheng Ge.   

Abstract

OBJECTIVE: To investigate the effects of long-term low dose hormone replacement therapy (HRT) on postmenopausal women in hormone level, cognition score, hippocampus volume, and magnetic resonance spectroscopy (MRS) parameters.
METHODS: A total of 182 postmenopausal women aged 50-87 years were chosen at Peking Union Medical College Hospital and assigned to HRT group and control group. The volunteers of HRT group had taken low dose hormone [estradiol (E2) 0.5-1.0 mg and progesterone 0.5-2.0 mg, once a day] for 4-33 years. The concentrations of E2, progesterone, and testosterone were measured using enzyme-linked immunosorbent assay (ELISA). The gene types of apolipoprotein E (ApoE) were measured by polymerase chain reaction, and the subjects with susceptible genes (ApoE epsilon3/epsilon4) of Alzheimer's disease (AD) were screened. Their hippocampus volumes and MRS parameters were obtained through magnetic resonance imaging (MRI), and results in two groups were analyzed by statistical method.
RESULTS: Compared with control group, the concentrations of E2 at each age stage in HRT group were significantly higher (P < 0.05) except the 80-89 years old subgroup; yet, there were no statistical differences in the concentrations of progesterone and testosterone between the two groups. There was no obvious difference in ApoE subtypes distribution between the two groups. The results of hippocampus MRI for the subjects with susceptible genes ApoE epsilon3/epsilon4 (HRT group 14 cases, control group 11 cases) showed that the ratio of bilateral hippocampus volume to whole brain volume in HRT group (0.406 +/- 0.028) was significantly higher than control group (0.369 +/- 0.031, P < 0.05). The results of 1H MRS for the subjects with susceptible genes ApoE epsilon3/epsilon4 (HRT group 12 cases, control group 11 cases) showed that the N-acetylaspartate/total creatine at the area of hippocampus in HRT group (1.54 +/- 0.08) were significantly higher than control group (1.45 +/- 0.13, P < 0.05).
CONCLUSIONS: For postmenopausal women, long-term low dose HRT can maintain the physiological concentration of E2 in plasma. Furthermore, the hippocampus MRI performed on those with ApoE epsilon3/epsilon4 genes shows that long-term low dose HRT can prevent hippocampus atrophy, which is beneficial to maintain the brain function and prevent AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17249194

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN: 1001-9294


  12 in total

1.  Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity.

Authors:  Yolanda R Smith; Luvina Bowen; Tiffany M Love; Alison Berent-Spillson; Kirk A Frey; Carol C Persad; Nancy K Reame; Robert A Koeppe; Jon-Kar Zubieta
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

Review 2.  GPR30 is positioned to mediate estrogen effects on basal forebrain cholinergic neurons and cognitive performance.

Authors:  R Hammond; R B Gibbs
Journal:  Brain Res       Date:  2010-12-05       Impact factor: 3.252

3.  Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial.

Authors:  Whitney Wharton; Laura D Baker; Carey E Gleason; Maritza Dowling; Jodi H Barnet; Sterling Johnson; Cynthia Carlsson; Suzanne Craft; Sanjay Asthana
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease.

Authors:  Daniel Havas; Birgit Hutter-Paier; Kiren Ubhi; Edward Rockenstein; Karl Crailsheim; Eliezer Masliah; Manfred Windisch
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 5.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

6.  Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease.

Authors:  Whitney Wharton; Carey E Gleason; Katelin R Lorenze; Tamara S Markgraf; Michele L Ries; Cynthia M Carlsson; Sanjay Asthana
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

Review 7.  Dehydroepiandrosterone and age-related cognitive decline.

Authors:  Krystina G Sorwell; Henryk F Urbanski
Journal:  Age (Dordr)       Date:  2009-08-27

8.  A cross-sectional study of hormone treatment and hippocampal volume in postmenopausal women: evidence for a limited window of opportunity.

Authors:  Kirk I Erickson; Michelle W Voss; Ruchika S Prakash; Laura Chaddock; Arthur F Kramer
Journal:  Neuropsychology       Date:  2010-01       Impact factor: 3.295

Review 9.  Neurobiological mechanisms underlying sex-related differences in stress-related disorders: Effects of neuroactive steroids on the hippocampus.

Authors:  Katharina M Hillerer; David A Slattery; Belinda Pletzer
Journal:  Front Neuroendocrinol       Date:  2019-09-30       Impact factor: 8.606

Review 10.  Estrogens, hormone therapy, and hippocampal volume in postmenopausal women.

Authors:  Alexis Wnuk; Donna L Korol; Kirk I Erickson
Journal:  Maturitas       Date:  2012-08-02       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.